CD274 and neoplasm: In addition to carrying PD-L1 [129,130], tumor-derived EVs induce various cellular components involved in tumor progression, including the conversion of immature myeloid cells (IMC) into MDSCs, which contribute to immunosuppression, by disrupting T cell functions [79,136].